Skip to content

Validation of a self-administered questionnaire to determine the severity of Hidradenitis Suppurativa

Hurley staging versus self administered questionnaire to determine the severity of Hydradentitis Suppurativa

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12615000030572
Enrollment
117
Registered
2015-01-19
Start date
2015-03-04
Completion date
2015-08-25
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Hidradenitis Suppurativa (HS) is a chronic skin disease that appears as pea-sized to marble-sized lumps under the skin. The lumps form most often in the armpits, under the breasts, inner thighs, groin and buttocks. HS can be painful and cause scarring and pus in affected areas. Flare-ups may be triggered by perspiration, hormonal changes (such as monthly cycles in women), humidity and heat, and friction from clothing. The current standard for diagnosing and assessing your condition is called the Hurley Stage Method. This involves a physical assessment of your skin by your doctor. Recently a new tool has been developed to diagnose Hidradentitis Suppurativa called a ‘self administered questionnaire’. The purpose of this research is to investigate the predictive ability, sensitivity and specificity of this self-administered questionnaire against the gold-standard clinical assessment of Hidradentitis Suppurativa severity using the Hurley stage method. The ability of self-administered questionnaires to assess disease severity has not been assessed. A self-administered questionnaire offers advantages over physical assessment, particularly for epidemiologic research into HS where it is important to be able to determine both the prevalence and severity of disease.

Interventions

This cross sectional observational study will used to compare a self administered questionnaire against a gold standard clinical assessment for diagnosis of severity of Hydradentitis Supperativa (HS). The gold standard clinical assessment will be the Hurley stage method. The medical care of the patient will not alter as a result of being involved in this study. The patient will visit a clinic for 1-2 hours where the patient will complete the self administered HS questionnaire, Quality of Life q

This cross sectional observational study will used to compare a self administered questionnaire against a gold standard clinical assessment for diagnosis of severity of Hydradentitis Supperativa (HS). The gold standard clinical assessment will be the Hurley stage method. The medical care of the patient will not alter as a result of being involved in this study. The patient will visit a clinic for 1-2 hours where the patient will complete the self administered HS questionnaire, Quality of Life questionnaire and undergo clinical assessment. Study endpoints will be the Hurley Stage, DLQi and the completed HS severity questionnaire. The utility of each of the possible 8 questions of the questionnaire will be evaluated through regression models and the agreement determined between the best model and the Hurley stage method.

Sponsors

Abbvie Pty Ltd
Lead SponsorCommercial sector/Industry

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients with a diagnosis of Hidradenitis Suppurativa (HS) who are aged 18 years or older will be eligible for this study.

Exclusion criteria

No exclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026